微信扫码
暂无在线客服
用户中心 意见反馈
返回顶部
产品详情
Product name:
Cardiac Marker
brief introduction:
Cardiac Marker

details

Cardiac Marker
Catalog No.Product NameSpecimenFormatPCSSensitivityCE
CTNI3002Cardiac Troponin I Rapid TestS/PCassette25/40T0.5ng/mlCE/NMPA
CTNI4002Cardiac Troponin I Rapid TestWB/S/PCassette25/40T0.5ng/mlCE/NMPA
CCK3002Creatine Kinase-MB Rapid TestS/PCassette25/40T5ng/mlCE
CCK4002Creatine Kinase-MB Rapid TestWB/S/PCassette25/40T5ng/mlCE
CMCT3312Myoglobin/CK-MB/Troponin I Tri-line Rapid TestS/PCassette25/40T50/5/0.5ng/mlCE
CMCT4312Myoglobin/CK-MB/Troponin I Tri-line Rapid TestWB/S/PCassette25/40T50/5/0.5ng/mlCE
CMYO3002Myoglobin Rapid TestS/PCassette25/40T50ng/mlCE
CMYO4002Myoglobin Rapid TestWB/S/PCassette25/40T50ng/mlCE

Advantage

  • 21 years experience
  • Simple operation, reliable result
  • High sensitivity and specificity,precision 
  • Cardic Marker test kits

 

Introduction

Product

TRO Rapid Test kit

Specimen

Whole blood,plasma,serum

Components

Individually packed test devices, Disposable pipettes, Buffer, Package insert

Sensitivity 

100%

Specificity 

99.8%

Overall agreement

99.8%

Storage 

2-30

Validity

24 Months

 

Cardiac Troponin I (cTnI) is a protein found in cardiac muscle with a molecular weight of 22.5 kDa.1 Troponin I is part of a three subunit complex comprising of Troponin T and Troponin C. Along with tropomyosin, this structural complex forms the main component that regulates the calcium sensitive ATPase activity of actomyosin in striated skeletal and cardiac muscle.2 After cardiac injury occurs, Troponin I is released into the blood 4-6 hours after the onset of pain. The release pattern of cTnI is similar to CK-MB, but while CK-MB levels return to normal after 72 hours, Troponin I remains elevated for 6-10 days, thus providing for a longer window of detection for cardiac injury. The high specificity of cTnI measurements for the identification of myocardial damage has been demonstrated in conditions such as the perioperative period, after marathon runs, and blunt chest trauma.cTnI release has also been documented in cardiac conditions other than acute myocardial infarction (AMI) such as unstable angina, congestive heart failure, and ischemic damage due to coronary artery bypass surgery.4 Because of its high specificity and sensitivity in the myocardial tissue, Troponin I has recently become the most preferred biomarker for myocardial infarction.5

The Troponin I Rapid Test Device (Whole Blood/Serum/Plasma) is a simple test that utilizes a combination of anti cTnI antibody coated particles and capture reagent to selectively detect cTnI in whole blood, serum or plasma. The minimum detection level is 0.5 ng/mL.

 

Intend to use

 

The One Step TRO Test Device (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of human Myoglobin,

 

Operating  Steps

201911131573649076953.jpg